Breast cancer risk from using HRT is ‘twice what was thought’
Study prompts medicines regulator to advise all women using HRT to remain vigilantThe risk of breast cancer from using hormone replacement therapy is double what was previously thought, according to a major piece of research, which confirms that HRT is a direct cause of the cancer.The findings of the definitive study will cause concern among the 1 million women in the UK and millions more around the world who are using HRT. It finds that the longer women take it, the greater their risk, with the possibility that just one year is risk-free. It also finds that the risk does not go away as soon as women stop taking it, as had...
Source: Guardian Unlimited Science - August 30, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Cancer research Menopause Medical research Drugs Ageing Science Breast cancer Health Society UK news Source Type: news
Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping
New data has confirmed that the risk of breast cancer is increased during use of all types of HRT, except vaginal oestrogens, and have also shown that an excess risk of breast cancer persists for long (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 30, 2019 Category: Drugs & Pharmacology Source Type: news
Hormone replacement therapy may raise the risk of breast cancer
Women aged 50 to 69 who take the most common type of HRT for five years or more run a 32 per cent risk of developing breast cancer s Oxford research says the therapy causes one in 20 cases. (Source: the Mail online | Health)
Source: the Mail online | Health - August 30, 2019 Category: Consumer Health News Source Type: news
Drug Supply issues: Sayana Press (medroxyprogesterone acetate) and Hormone replacement therapy (HRT)
Information from the Department of Health and Social Care (DHSC) regarding the following supply issues... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 28, 2019 Category: Drugs & Pharmacology Source Type: news
The Guardian view on the menopause at work: a healthy conversation | Editorial
From new employee entitlements to soap opera storylines, older women ’s health needs a bigger profileConnected as it is with ageing, it is not surprising that the menopause has a bad reputation. Even for women who have generally found their periods to be a nuisance, the cessation of the monthly cycle of egg production often comes as a shock. As well as the psychological impact of what used to euphemistically be called “the change”, the menopause brings with it symptoms for which a lot of women find themselves alarmingly unprepared – asmany readers told us when we invited them to share their stories.These symptoms i...
Source: Guardian Unlimited Science - August 27, 2019 Category: Science Authors: Editorial Tags: Menopause Health Women Television industry Feminism World news Science Work & careers Guardian Careers Money Media Society Life and style Source Type: news
